VCRE Vicore Pharma Holding AB
$10.78▼ -6.34%
Healthcare
Other
After hours
$10.70▼ -0.74%
Sep 11, 7:59 PM ET
Volume 12.8K
Avg Volume (10D) 12.2K
Key Metrics & Fundamentals
Market Cap
$303.48M
P/E Ratio
–
Div Yield
–%
52W Range
10.47 - 17.80
% vs 50 MA
–%
% vs 200 MA
–%
RSI-14
42.7
MACD Histogram
+0.0700
Beta (1Y vs SPY)
1.42
Free Cash Flow
-$155.92M
Gross Rev
$2.21M
Gross Profit
$2.21M
EBITDA
-$142.67M
COGS
–
Operating Exp
$152.32M
Operating Income
-$150.10M
EBIT
-$150.10M
Pretax Income
-$142.67M
Net Income
-$142.84M
EPS (Diluted)
-5.10
Price & Volume History
Loading chart…
Recent News
Vicore Pharma to Participate in Upcoming Healthcare Conferences
ACCESS Newswire · Sep 1, 2026 6:20 AM
Vicore Pharma to Present at The Pareto Securities 17th Annual Healthcare Conference
ACCESS Newswire · Aug 26, 2026 6:20 AM
Vicore Pharma to Present at the European Respiratory Society Congress 2026
ACCESS Newswire · Aug 24, 2026 6:15 AM
Vicore Pharma to Participate in the Leerink Therapeutics Forum
ACCESS Newswire · Jul 7, 2026 6:20 AM
Citi Appointed as Depositary Bank for Vicore Pharma Holding AB’s ADR Program
Business Wire · Jul 6, 2026 7:00 AM
Vicore Pharma Appoints Rob Slack as Chief Scientific Officer
ACCESS Newswire · Jul 6, 2026 6:20 AM
Financial Overview - Income Statement
Quarterly
Jun 2026
See VCRE's money flow as a full page
Social Sentiment
No Reddit posts found for VCRE.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.